Form 4: Onconetix Director Simon Tarsh Reports Stock Award and Disposal

Director Simon Tarsh reports acquisition of restricted stock and disposal of common stock in Onconetix, Inc.

Summary

• On September 26, 2024, Simon Tarsh, a director of Onconetix, Inc., reported a transaction involving the company's stock.
• Tarsh acquired 3,318 shares of common stock through a restricted stock award.
• The restricted stock award was granted under the Issuer's 2022 Equity Incentive Plan, as amended.
• These shares will vest on August 31, 2025, contingent upon Tarsh's continued service as a non-employee director.
• Tarsh also disposed of 169 shares of common stock.
• Following the reported transactions, Tarsh beneficially owns 3,477 shares of Onconetix common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The stock award is a positive sign, but the disposal is a negative sign.

Positives

• The grant of restricted stock to a director aligns their interests with the long-term performance of the company.
• Continued service as a director is tied to the vesting of the shares.

Future Outlook

The vesting of the restricted stock is contingent upon continued service as a non-employee director until August 31, 2025.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the actions of company directors and officers.

Stakeholder Impact

• Shareholders are informed about the director's stock transactions, providing insight into management's alignment with company performance.

Key Dates

Keywords

Onconetix, Director, Simon Tarsh, Stock Award, Beneficial Ownership, Form 4, Equity Incentive Plan, Restricted Stock